Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shailender Bhatia

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Journal for Immunotherapy of Cancer|August 18, 2022
Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review studyShailender Bhatia, Paul Nghiem, S Phani Veeranki, et al.
Future Oncology (London, England)|January 29, 2021
How we treat Merkel cell carcinoma: within and beyond current guidelinesSong Y Park, Coley Doolittle-Amieva, Yasman Moshiri, et al.
JAAD Case Reports|January 9, 2023
Clitoral metastasis of vulvar melanoma treated with talimogene laherparepvecErin M McClure, Neha Singh, Kim G Abson, et al.
Targeted Oncology|July 26, 2020
Untangling the Multidisciplinary Care Web: Streamlining Care Through an Immune-Related Adverse Events (IRAE) Tumor BoardLaura C Kennedy, Kit Man Wong, Nikhil V Kamat, et al.
Frontiers in Oncology|January 19, 2024
Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors: a pooled meta-analysis of 1735 patientsIuliia Kovalenko, Wern Lynn Ng, Yimin Geng, et al.
Journal of the American Academy of Dermatology|January 6, 2024
Prognosis of Merkel cell carcinoma patients with autoimmune disorders, other types of immune dysfunction, or immunocompetent status: Analysis of 762 patientsSong Y Park, Daniel S Hippe, Lauren Zawacki, et al.
European Heart Journal. Case Reports|February 18, 2025
Successful treatment of immune checkpoint inhibitor-associated fulminant myocarditis with abatacept and ruxolitinib: a case reportElena Wadden, Carol Lai, Petros Grivas, et al.
Cancers|July 29, 2025
Sonographic Signatures of Immune Checkpoint Inhibitor-Associated Musculoskeletal Adverse EventsHans Vitzthum von Eckstaedt, Kevin Weng, Ingeborg Sacksen, et al.
Journal of the American Academy of Dermatology|January 7, 2014
Clinical utility of a circulating tumor cell assay in Merkel cell carcinomaAstrid Blom, Shailender Bhatia, Stephanie Pietromonaco, et al.
American Journal of Clinical Oncology|September 14, 2018
Differential Outcomes Among Immunosuppressed Patients With Merkel Cell Carcinoma: Impact of Immunosuppression Type on Cancer-specific and Overall SurvivalMaclean Cook, Kelsey Baker, Mary Redman, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|August 18, 2022
Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review studyShailender Bhatia, Paul Nghiem, S Phani Veeranki, et al.
Future Oncology (London, England)|January 29, 2021
How we treat Merkel cell carcinoma: within and beyond current guidelinesSong Y Park, Coley Doolittle-Amieva, Yasman Moshiri, et al.
JAAD Case Reports|January 9, 2023
Clitoral metastasis of vulvar melanoma treated with talimogene laherparepvecErin M McClure, Neha Singh, Kim G Abson, et al.
Targeted Oncology|July 26, 2020
Untangling the Multidisciplinary Care Web: Streamlining Care Through an Immune-Related Adverse Events (IRAE) Tumor BoardLaura C Kennedy, Kit Man Wong, Nikhil V Kamat, et al.
Frontiers in Oncology|January 19, 2024
Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors: a pooled meta-analysis of 1735 patientsIuliia Kovalenko, Wern Lynn Ng, Yimin Geng, et al.
Journal of the American Academy of Dermatology|January 6, 2024
Prognosis of Merkel cell carcinoma patients with autoimmune disorders, other types of immune dysfunction, or immunocompetent status: Analysis of 762 patientsSong Y Park, Daniel S Hippe, Lauren Zawacki, et al.
European Heart Journal. Case Reports|February 18, 2025
Successful treatment of immune checkpoint inhibitor-associated fulminant myocarditis with abatacept and ruxolitinib: a case reportElena Wadden, Carol Lai, Petros Grivas, et al.
Cancers|July 29, 2025
Sonographic Signatures of Immune Checkpoint Inhibitor-Associated Musculoskeletal Adverse EventsHans Vitzthum von Eckstaedt, Kevin Weng, Ingeborg Sacksen, et al.
Journal of the American Academy of Dermatology|January 7, 2014
Clinical utility of a circulating tumor cell assay in Merkel cell carcinomaAstrid Blom, Shailender Bhatia, Stephanie Pietromonaco, et al.
American Journal of Clinical Oncology|September 14, 2018
Differential Outcomes Among Immunosuppressed Patients With Merkel Cell Carcinoma: Impact of Immunosuppression Type on Cancer-specific and Overall SurvivalMaclean Cook, Kelsey Baker, Mary Redman, et al.
Pageof 13